Wockhardt Bio Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Wockhardt Bio Stock Forecast and Price Target
The average price target of 1.07 for Wockhardt Bio's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 4.9% from the last closing price in November, 2021 if reached by the end of the year. This potential increase is based on a high estimate of 1.20 and a low estimate of 0.96. If you are not interested in WBIO stock, you may still be interested in its competitors and their current standings.
4.90% Upside
Wockhardt Bio Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Wockhardt Bio's Price has grown, moving from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to 1.02 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.99 | Buy/Sell | CHF115.58 | 16.50% |
ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF242.00 | Buy/Sell | CHF307.83 | 11.57% |
NOVN Stock Forecast | Novartis | Outperform |
10
|
CHF88.80 | Buy/Sell | CHF105.00 | 23.95% |
CFR Stock Forecast | Compagnie Financière Richemon... | Outperform |
17
|
CHF144.95 | Buy/Sell | CHF147.55 | 4.45% |
ABBN Stock Forecast | ABB Ltd | Hold |
11
|
CHF40.95 | Buy/Sell | CHF42.44 | 5.05% |
Wockhardt Bio Revenue Forecast for 2023 - 2025 - 2030
In the last year, Wockhardt Bio's Revenue has seen a drop from 315.14M to 264.94M – a 15.93% decrease. In the next year, analysts predict that Revenue will jump to 315.15M – up 18.95% from the current level. Looking ahead to nine years, experts forecast that Revenue will grow by 13.73%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GLEN Stock Forecast | Glencore | Outperform |
2
|
£3.98 | Buy/Sell | £6.66 | 52.26% |
HOLN Stock Forecast | Holcim Ltd | Outperform |
12
|
CHF75.28 | Buy/Sell | CHF64.56 | -0.37% |
TEL Stock Forecast | TE Connectivity | Outperform |
10
|
$141.03 | Buy/Sell | $158.67 | 12.03% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF3.94k | Buy/Sell | CHF3.14k | -16.22% |
LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF458.20 | Buy/Sell | CHF516.89 | 12.61% |
PGHN Stock Forecast | Partners Group Holding | Outperform |
10
|
CHF1.27k | Buy/Sell | CHF1.07k | -5.81% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
KNIN Stock Forecast | Kuehne + Nagel International | Underperform |
8
|
CHF245.40 | Buy/Sell | CHF246.86 | -3.83% |
DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
104.30€ | Buy/Sell | 114.60€ | 15.05% |
SCMN Stock Forecast | Swisscom | Hold |
14
|
CHF508.80 | Buy/Sell | CHF558.69 | 13.01% |
Wockhardt Bio EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Wockhardt Bio's EBITDA has decreased from 35.04M to 22.84M – a 34.82% drop. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach 35.04M – an increase of 53.42%. Over the next nine years, experts anticipate that EBITDA growth for Wockhardt Bio will be 44.57%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LISN Stock Forecast | Hold |
3
|
CHF109.40k | Buy/Sell | CHF103.73k | 0.55% | |
SCHN Stock Forecast | Schindler Holding | Outperform |
16
|
CHF223.80 | Buy/Sell | CHF209.44 | 2.77% |
GEBN Stock Forecast | Geberit | Underperform |
18
|
CHF526.60 | Buy/Sell | CHF439.17 | -16.45% |
Wockhardt Bio EBIT Forecast for 2023 - 2025 - 2030
In the last year, Wockhardt Bio's EBIT has decreased by 54.07%, going from 26.30M to 12.08M. In the next year, analysts predict that EBIT will reach 26.30M – an increase of 117.72%. For the next nine years, the forecast is for EBIT to grow by 121.90%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SGSN Stock Forecast | SGS | Hold |
18
|
CHF87.16 | Buy/Sell | CHF86.34 | 0.39% |
EMSN Stock Forecast | EMS-CHEMIE HOLDING | Hold |
18
|
CHF619.00 | Buy/Sell | CHF657.14 | 2.91% |
AMCR Stock Forecast | Amcor | Hold |
13
|
$9.47 | Buy/Sell | $9.67 | 5.07% |
Wockhardt Bio EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Wockhardt Bio's EPS has grown, moving from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to 0.00 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LOGN Stock Forecast | Logitech International | Hold |
18
|
CHF79.30 | Buy/Sell | CHF73.92 | 4.56% |
CSGN Stock Forecast | Credit Suisse Group | - |
11
|
CHF0.75 | Buy/Sell | CHF1.51 | -100.00% |
BAER Stock Forecast | Julius Bär Gruppe | Outperform |
14
|
CHF50.46 | Buy/Sell | CHF64.09 | 12.96% |